News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

A Pill May Soon Replace Mylan (MYL)'s Costly EpiPen



11/21/2016 7:03:54 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
As allergy sufferers reel from the soaring costs of the EpiPen — a handheld auto-injection device of epinephrine made by Mylan that prevents life-threatening anaphylactic shock — a new oral tablet alternative is being tested that could solve a host of issues.

This comes at a time when the price of the injector has skyrocketed 500 percent since 2007. It now costs $500. That's an expensive dilemma for approximately 43 million people suffering from life-threatening allergies in the United States. Many find the price tag prohibitively expensive.

According to Popular Science, a researcher at Nova Southeastern University in Florida is responding to both the consumer outrage over the EpiPen price hike as well as to Mylan's monopoly on the device. Rather than create a new epinephrine injector, pharmaceutical researcher Mutasem Rawas-Qalaji has been exploring the development of an Epi-Pill, an epinephrine tablet that dissolves under the tongue.

Read at CNBC


comments powered by Disqus
CNBC
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES